Dan Loeb’s Third Point builds stake in maker of Tylenol and Neutrogena
Source: Financial Times | Published: April 25, 2025, 9:22 p.m.
Johnson & Johnson spin-off Kenvue may become takeover target as activists circle the consumer health group
Read Original Article
Back to News List